Mednax Inc (MD)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | 0 |
| Total stockholders’ equity | US$ in thousands | 849,061 | 891,632 | 896,487 | 747,485 | 1,499,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $849,061K
= 0.00
The debt-to-equity ratio of Pediatrix Medical Group Inc has been fluctuating over the past five years. In 2023 and 2022, the company's debt-to-equity ratio was 0.75 and 0.73 respectively, indicating a moderate level of financial leverage with more emphasis on equity financing compared to debt. This suggests that the company has a relatively strong financial position in terms of its capital structure.
However, in 2021, the debt-to-equity ratio increased significantly to 1.12, suggesting a higher level of debt relative to equity. This increase may indicate a change in the company's financing strategy, potentially taking on more debt to fund operations or investments.
The sharp spike in the debt-to-equity ratio in 2020 to 2.33 signifies a substantial increase in debt compared to equity, which could hint at financial risk or liquidity concerns. It would be essential to investigate the reasons behind this sudden increase and assess the company's ability to manage its debt obligations effectively.
In 2019, the debt-to-equity ratio was 1.15, reflecting a relatively balanced mix of debt and equity financing. This ratio indicates that the company had a slightly higher amount of debt compared to equity in that year.
In summary, monitoring the trend of Pediatrix Medical Group Inc's debt-to-equity ratio is crucial to understanding the company's financing decisions and assessing its overall financial health and risk profile over time.
Peer comparison
Dec 31, 2023